The AVIATOR Study: Trastuzumab and Vinorelbine With Avelumab OR Avelumab & Utomilumab in Advanced HER2+ Breast Cancer
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Vinorelbine|DRUG: Trastuzumab|DRUG: Avelumab|DRUG: Utomilumab
Sponsor: Adrienne G. Waks
Collaborators: Pfizer|Breast Cancer Research Foundation|Johns Hopkins University